M. Schreckenberger - Concepedia

Author

M. Schreckenberger

Johannes Gutenberg University Mainz

Also Known As

M Schreckenberger, M. SCHRECKENBERGER, M. Schreckenberger, P. Reinartz, Schreckenberger M, U. Cremerius

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz FH Aachen University Medical Center of the Johannes Gutenberg University Mainz Technical University of Munich Saarland University

About

M. Schreckenberger is an author at Johannes Gutenberg University Mainz specializing in medicine, medical imaging, and biomedical imaging.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	343
2	Health Sciences	5	5	392
3	Engineering	4	4	280
4	Social Sciences	1	1	32
5	Cell Biology	1	1	29

M. Schreckenberger

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies Markus F. Neurath, Dirk Vehling, K. Schunk, The American Journal of Gastroenterology	2002	188
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial Ursula Nestle, Tanja Schimek‐Jasch, Stephanie Kremp, The Lancet Oncology EngineeringOncologic ImagingMedical ImagingBiomedical ImagingMolecular Imaging	2020	169
The unpleasantness of tonic pain is encoded by the insular cortex M. Schreckenberger, Thomas Siessmeier, A. Viertmann, Neurology	2005	163
6-<sup>18</sup>F-Fluoro-<scp>l</scp>-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to<sup>123</sup>I-Metaiodobenzyl-Guanidine Scintigraphy in the Detection of Extraadrenal and Hereditary Pheochromocytomas and Paragangliomas: Correlation with Vesicular Monoamine Transporter Expression Christian Fottner, Andreas Helisch, Martin Anlauf, The Journal of Clinical Endocrinology & Metabolism	2010	131
Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics. Osama Sabri, R. Erkwoh, M. Schreckenberger, PubMed	1997	92
PET- und SPECT-Untersuchungen von Hirn tumoren mit radioaktiv markierten Aminosäuren P. Bartenstein, Henning Boecker, P. Brust, Nuklearmedizin - NuclearMedicine Amino AcidsPet-mriPathologyGliomaPositron Emission Tomography	2011	84
Functional MRI and 18F FDG-Positron Emission Tomography for Presurgical Planning: Comparison with Electrical Cortical Stimulation Timo Krings, M. Schreckenberger, Veit Rohde, Acta Neurochirurgica Fdg-positron Emission TomographyNeuroimaging ModalityMedical ImagingNeuroanatomyDiagnostic Neuroradiology	2002	56
Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET S. Behnke, Ute Schroeder, Ulrich Dillmann, NeuroImage Substantia NigraNeuroanatomyPet-mriF-dopa PetNeuroimaging	2009	49
PET Lung Ventilation/Perfusion Imaging Using 68Ga Aerosol (Galligas) and 68Ga-Labeled Macroaggregated Albumin Stephan Ament, Stephan Maus, Helmut Reber, Recent results in cancer research/Recent Results in Cancer Research Positron Emission TomographyLung DepositionMedical ImagingPet-mriBiomedical Imaging	2012	47
Comparison of visual and ROI-based brain tumour grading using 18F-FDG PET: ROC analyses Philipp T. Meyer, M. Schreckenberger, Uwe Spetzger, European Journal of Nuclear Medicine and Molecular Imaging EngineeringPet-mriGliomaPositron Emission TomographyNeuro-oncology	2001	46

Page 1